Stock Evaluator: Rafael Holdings, Inc. (RFL)

Rafael Holdings, Inc. RFL

$2.52 0.01 0.40%
September 3, 2026 11:58:49 AM EST November 10, 2021 Volume: 22,672
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Pharmaceuticals

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 ("NPC1"), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.

Commentary & Analysis


Financial Summary

Share Statistics RFL Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $130.5 $674.0 24%
Shares Out (Mil) 51.2 43.9 48%
Institutional Ownership 16.6% 84.7% 8%
Float (Mil) 31.8 47.3 37%
Beta 0.29 0.71 17%
Avg Daily Volume (000s) 122 293 39%
Price Change
(52-week)
81.9% 68.8% 89%
Growth RFL Industry
Median
Percentile
(All Stocks)
Sales (5yr) (28.7%) 6.8% 1%
Net Income (5yr) (24.0%) (1.5%) 17%
EPS (5yr) (9.5%) 14.9% 22
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 45.8% (15.1%) 92%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials RFL Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1 $317 2%
Net Income (TTM) (Mil) ($33) ($11) 20%
EPS (TTM) ($0.663) ($0.700) 25%
Operating Cash Flow (TTM) (Mil) ($32) ($7) 12%
Net Cash Flow (TTM) (Mil) ($7) $4 32%
Long-Term Debt (Q1) (Mil) $0 $6 0%
Enterprise Value (Q1) (Mil) $94 $575 21%
Valuation RFL Industry
Median
Percentile
(All Stocks)
P/B 1.73 2.80 44%
P/E na 17.4 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.1 na
Ratios RFL Industry
Median
Percentile
(All Stocks)
Gross Margin 95.1% 67.5% 95%
Net Margin na (1.4%) na
ROA (32.5%) (24.6%) 16%
ROE (41.7%) (21.4%) 17%
Liabilities to Assets 12.2% 32.2% 7%
F-Score 3 3 18%

Rafael Holdings, Inc. did not pass any screens on 9/2/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors